Use of human chorionic gonadotropin in the prevention of breast cancer

ISSN： 1745-5057

Source： Women's Health, Vol.4, Iss.1, 2008-01, pp. : 1-5

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Human Chorionic Gonadotropin-Induced Hyperthyroidism in Germ Cell Cancer – a Case Presentation and Review of the Literature

Oncology Research and Treatment, Vol. 30, Iss. 6, 2007-06 ,pp. : 330-334

Karger

Access to resources Recommend Favorite

False-Positive Human Serum Chorionic Gonadotropin in a Patient with a History of Germ Cell Cancer

Oncology, Vol. 66, Iss. 4, 2004-06 ,pp. : 336-338

Karger

Access to resources Recommend Favorite

Human Chorionic Gonadotropin Deteriorates the Histology of Rat Testes

Urologia Internationalis, Vol. 76, Iss. 3, 2006-04 ,pp. : 274-277

Karger

Access to resources Recommend Favorite

Single‐dose pharmacokinetic study comparing the pharmacokinetics of recombinant human chorionic gonadotropin in healthy Japanese and Caucasian women and recombinant human chorionic gonadotropin and urinary human chorionic gonadotropin in healthy Japanese women

Reproductive Medicine and Biology, Vol. 17, Iss. 1, 2018-01 ,pp. : 52-58

John Wiley & Sons Inc

Access to resources Recommend Favorite

Maternal age and serum concentration of human chorionic gonadotropin in early pregnancy: influence of gonadotropin‐releasing hormone

ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA, Vol. 94, Iss. 4, 2015-04 ,pp. : 443-444

John Wiley & Sons Inc

Access to resources Recommend Favorite